Ahmed Ibrahim Hatata

Title : Role of intracoronary adenosine in prevention of no reflow guided by MVO by CMR

Abstract:

• The adenosine is an available drug  and the tool is ready for treatment of no reflow but how is the drug is used in prevention of no reflow was the study.
• In this study we used adenosine as primary intervention for no reflow after establishing TIMI I flow in primary PCI patients, then both groups who were given adenosine and not compared regarding LV mass and myocardial salvage index plus MV HG and MV obstruction
• This study can be more and more generalized to get more results.
• The results are more promising so we can expand the study among more and more cases.

Biography:

Dr. Ahmed Hatata studied medicine at the Ain-Shams University, Egypt and graduated in 2014. He then joined the residency program at the cardiology department from 2014 to 2017, Ain-shams University. I received my  MD degree in 2021 at the same institution. After three years fellowship supervised by Dr Wael E-Kilany at Ain-shams University , Egypt  I am now obtained the position of an lecturer of cardiology at the Ain-shams university.